Therapeutic-drug-monitoring-based ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem Cell Transplantation: a randomized, multicenter, phase 3 clinical trial.
- DOI
- 10.1016/j.canlet.2026.218766
- Published
- 2026 Oct 10
- Container
- Cancer letters
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.canlet.2026.218766,
title = {Therapeutic-drug-monitoring-based ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem Cell Transplantation: a randomized, multicenter, phase 3 clinical trial.},
author = {Dou L and Wang N and Zhang H and Yang J and Du J and Liu Q and Zhang X and Li F and Boelens JJ and Wang H and Cao W and Zhang X and Liu D},
year = {2026},
journal = {Cancer letters},
doi = {10.1016/j.canlet.2026.218766},
url = {https://doi.org/10.1016/j.canlet.2026.218766}
}RIS
TY - JOUR TI - Therapeutic-drug-monitoring-based ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem Cell Transplantation: a randomized, multicenter, phase 3 clinical trial. AU - Dou L AU - Wang N AU - Zhang H AU - Yang J AU - Du J AU - Liu Q AU - Zhang X AU - Li F AU - Boelens JJ AU - Wang H AU - Cao W AU - Zhang X AU - Liu D PY - 2026 JO - Cancer letters DO - 10.1016/j.canlet.2026.218766 UR - https://doi.org/10.1016/j.canlet.2026.218766 ER -
APA
L, D., N, W., H, Z., J, Y., J, D., Q, L., X, Z., F, L., JJ, B., H, W., W, C., X, Z., & D, L. (2026). Therapeutic-drug-monitoring-based ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem Cell Transplantation: a randomized, multicenter, phase 3 clinical trial.. Cancer letters. https://doi.org/10.1016/j.canlet.2026.218766
Source records
- pubmed · retrieved 2026-09-27T00:35:30.864Z